The Global Neurodiagnostics Market to grow USD 8,349.12 Million by 2025, at a CAGR of 7.54%.

The Global Neurodiagnostics Market is expected to grow from USD 5,397.43 Million in 2019 to USD 8,349.12 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.54%.

Market Segmentation & Coverage:

This research report categorizes the Neurodiagnostics to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Neurodiagnostics Market studied across Clinical Testing Instrument, Diagnostic & Imaging System, and Reagent & Consumable. The Clinical Testing Instrument further studied across NGS Instrument, PCR Instrument, and Sanger Sequencer. The Diagnostic & Imaging System further studied across Angiography System, CT Scanner, EEG System, EMG Device, MEG Device, MRI System, PET Scanner, and Ultrasound Imaging System. The Reagent & Consumable further studied across Antibody, Buffer, Enzyme, Protein, & Peptide, Media & Sera, Probe, and Solvent.

"The Epilepsy is projected to witness the highest growth during the forecast period"

Based on Indication, the Neurodiagnostics Market studied across Epilepsy, Headache Disorder, Neurodegenerative Diseases, Sleep Disorder, and Stroke. The Neurodegenerative Diseases commanded the largest size in the Neurodiagnostics Market in 2019. On the other hand, the Epilepsy is expected to grow at the fastest CAGR during the forecast period.

"The Neurology Center is projected to witness the highest growth during the forecast period"

Based on End User, the Neurodiagnostics Market studied across Diagnostic Laboratory & Imaging Center, Hospital & Clinic, Ambulatory Care Center, and Neurology Center. The Hospital & Clinic commanded the largest size in the Neurodiagnostics Market in 2019. On the other hand, the Neurology Center is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Neurodiagnostics Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Neurodiagnostics Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Neurodiagnostics Market including Advanced Brain Monitoring, Inc., Bio-Rad Laboratories, Canon, Inc., F. Hoffmann-La Roche AG, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., Lifelines Neuro Company, LLC, Mitsar Co., Ltd., Natus Medical Incorporated, Nihon Kohden Corporation, Philips Healthcare, QIAGEN N.V., Siemens Healthineers, and Thermo Fisher Scientific, Inc..

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Neurodiagnostics Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Neurodiagnostics Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Neurodiagnostics Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Neurodiagnostics Market?

4. What is the competitive strategic window for opportunities in the Global Neurodiagnostics Market?

5. What are the technology trends and regulatory frameworks in the Global Neurodiagnostics Market?

6. What are the modes and strategic moves considered suitable for entering the Global Neurodiagnostics Market?

1.1. Objectives of the Study

1.2. Market Segmentation & Coverage

1.3. Years Considered for the Study

1.4. Currency & Pricing

1.5. Language

1.6. Stakeholders

2.1. Research Process

2.1.1. Define: Research Objective

2.1.2. Determine: Research Design

2.1.3. Prepare: Research Instrument

2.1.4. Collect: Data Source

2.1.5. Analyze: Data Interpretation

2.1.6. Formulate: Data Verification

2.1.7. Publish: Research Report

2.1.8. Repeat: Report Update

2.2. Research Execution

2.2.1. Initiation: Research Process

2.2.2. Planning: Develop Research Plan

2.2.3. Execution: Conduct Research

2.2.4. Verification: Finding & Analysis

2.2.5. Publication: Research Report

2.3. Research Outcome

3.1. Market Outlook

3.2. Product Outlook

3.3. Indication Outlook

3.4. End User Outlook

3.5. Geography Outlook

3.6. Competitor Outlook

4.1. Introduction

5.1. Introduction

5.2. Drivers

5.2.1. Increasing incidences of neurological disorders worldwide

5.2.2. Growing awareness among patients for early disease diagnosis for effective treatment

5.2.3. Growing adoption of innovative diagnostic technologies

5.3. Restraints

5.3.1. Limited availability of skilled healthcare professionals

5.4. Opportunities

5.4.1. Advances in genomics and proteomics for neurodegenerative disorders diagnosis

5.4.2. Ongoing clinical trials

5.5. Challenges

5.5.1. High cost associated with the neurodiagnostic devices

6.1. Porters Five Forces Analysis

6.1.1. Threat of New Entrants

6.1.2. Threat of Substitutes

6.1.3. Bargaining Power of Customers

6.1.4. Bargaining Power of Suppliers

6.1.5. Industry Rivalry

6.2. Cumulative Impact of COVID-19

6.3. Client Customizations

7.1. Introduction

7.2. Clinical Testing Instrument

7.2.1. NGS Instrument

7.2.2. PCR Instrument

7.2.3. Sanger Sequencer

7.3. Diagnostic & Imaging System

7.3.1. Angiography System

7.3.2. CT Scanner

7.3.3. EEG System

7.3.4. EMG Device

7.3.5. MEG Device

7.3.6. MRI System

7.3.7. PET Scanner

7.3.8. Ultrasound Imaging System

7.4. Reagent & Consumable

7.4.1. Antibody

7.4.2. Buffer

7.4.3. Enzyme, Protein, & Peptide

7.4.4. Media & Sera

7.4.5. Probe

7.4.6. Solvent

8.1. Introduction

8.2. Epilepsy

8.3. Headache Disorder

8.4. Neurodegenerative Diseases

8.5. Sleep Disorder

8.6. Stroke

9.1. Introduction

9.2. Diagnostic Laboratory & Imaging Center

9.3. Hospital & Clinic

9.4. Ambulatory Care Center

9.5. Neurology Center

10.1. Introduction

10.2. Americas

10.2.1. Argentina

10.2.2. Brazil

10.2.3. Canada

10.2.4. Mexico

10.2.5. United States

10.3. Asia-Pacific

10.3.1. Australia

10.3.2. China

10.3.3. India

10.3.4. Indonesia

10.3.5. Japan

10.3.6. Malaysia

10.3.7. Philippines

10.3.8. South Korea

10.3.9. Thailand

10.4. Europe, Middle East & Africa

10.4.1. France

10.4.2. Germany

10.4.3. Italy

10.4.4. Netherlands

10.4.5. Qatar

10.4.6. Russia

10.4.7. Saudi Arabia

10.4.8. South Africa

10.4.9. Spain

10.4.10. United Arab Emirates

10.4.11. United Kingdom

11.1. Introduction

11.2. 360iResearch Competitive Strategic Window, by Product

11.3. 360iResearch Competitive Strategic Window, by Indication

11.4. 360iResearch Competitive Strategic Window, by End User

11.5. 360iResearch Competitive Strategic Window, by Geography

12.1. 360iResearch FPNV Positioning Matrix

12.1.1. Quadrants

12.1.2. Business Strategy

12.1.3. Product Satisfaction

12.2. 360iResearch Market Ranking Analysis

12.3. 360iResearch Market Share Analysis

12.4. 360iResearch Competitive Scenario

12.4.1. Merger & Acquisition

12.4.2. Agreement, Collaboration, & Partnership

12.4.3. New Product Launch & Enhancement

12.4.4. Investment & Funding

12.4.5. Award, Recognition, & Expansion

13.1. Advanced Brain Monitoring, Inc.

13.2. Bio-Rad Laboratories

13.3. Canon, Inc.

13.4. F. Hoffmann-La Roche AG

13.5. FUJIFILM Holdings Corporation

13.6. GE Healthcare

13.7. Hitachi, Ltd.

13.8. Lifelines Neuro Company, LLC

13.9. Mitsar Co., Ltd.

13.10. Natus Medical Incorporated

13.11. Nihon Kohden Corporation

13.12. Philips Healthcare

13.13. QIAGEN N.V.

13.14. Siemens Healthineers

13.15. Thermo Fisher Scientific, Inc.

14.1. Discussion Guide

14.2. Edition Details

14.3. License Details

14.4. Pricing Details

TABLE 1. GLOBAL NEURODIAGNOSTICS MARKET SIZE, 2017-2025 (USD MILLION)

TABLE 2. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 3. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CLINICAL TESTING INSTRUMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 4. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NGS INSTRUMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 5. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PCR INSTRUMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 6. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SANGER SEQUENCER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 7. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC & IMAGING SYSTEM, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 8. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANGIOGRAPHY SYSTEM, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 9. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY CT SCANNER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 10. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EEG SYSTEM, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 11. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EMG DEVICE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 12. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEG DEVICE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 13. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MRI SYSTEM, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 14. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PET SCANNER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 15. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING SYSTEM, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 16. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY REAGENT & CONSUMABLE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 17. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ANTIBODY, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 18. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY BUFFER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 19. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY ENZYME, PROTEIN, & PEPTIDE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 20. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY MEDIA & SERA, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 21. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY PROBE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 22. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SOLVENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 23. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 24. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY EPILEPSY, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 25. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HEADACHE DISORDER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 26. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 27. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY SLEEP DISORDER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 28. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY STROKE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 29. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 30. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORY & IMAGING CENTER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 31. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINIC, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 32. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY AMBULATORY CARE CENTER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 33. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY NEUROLOGY CENTER, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 34. GLOBAL NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 35. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 36. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 37. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 38. AMERICAS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 39. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 40. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 41. ARGENTINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 42. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 43. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 44. BRAZIL NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 45. CANADA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 46. CANADA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 47. CANADA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 48. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 49. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 50. MEXICO NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 51. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 52. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 53. UNITED STATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 54. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 55. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 56. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 57. ASIA-PACIFIC NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 58. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 59. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 60. AUSTRALIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 61. CHINA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 62. CHINA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 63. CHINA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 64. INDIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 65. INDIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 66. INDIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 67. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 68. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 69. INDONESIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 70. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 71. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 72. JAPAN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 73. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 74. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 75. MALAYSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 76. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 77. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 78. PHILIPPINES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 79. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 80. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 81. SOUTH KOREA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 82. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 83. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 84. THAILAND NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 85. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)

TABLE 86. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 87. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 88. EUROPE, MIDDLE EAST & AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 89. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 90. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 91. FRANCE NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 92. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 93. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 94. GERMANY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 95. ITALY NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 96. ITALY NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 97. ITALY NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 98. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 99. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 100. NETHERLANDS NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 101. QATAR NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 102. QATAR NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 103. QATAR NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 104. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 105. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 106. RUSSIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 107. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 108. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 109. SAUDI ARABIA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 110. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 111. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 112. SOUTH AFRICA NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 113. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 114. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 115. SPAIN NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 116. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 117. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 118. UNITED ARAB EMIRATES NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 119. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY PRODUCT, 2017-2025 (USD MILLION)

TABLE 120. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)

TABLE 121. UNITED KINGDOM NEURODIAGNOSTICS MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)

TABLE 122. GLOBAL NEURODIAGNOSTICS MARKET: SCORES

TABLE 123. GLOBAL NEURODIAGNOSTICS MARKET: BUSINESS STRATEGY

TABLE 124. GLOBAL NEURODIAGNOSTICS MARKET: PRODUCT SATISFACTION

TABLE 125. GLOBAL NEURODIAGNOSTICS MARKET: RANKING

TABLE 126. GLOBAL NEURODIAGNOSTICS MARKET: MERGER & ACQUISITION

TABLE 127. GLOBAL NEURODIAGNOSTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP

TABLE 128. GLOBAL NEURODIAGNOSTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT

TABLE 129. GLOBAL NEURODIAGNOSTICS MARKET: INVESTMENT & FUNDING

TABLE 130. GLOBAL NEURODIAGNOSTICS MARKET: AWARD, RECOGNITION, & EXPANSION

TABLE 131. GLOBAL NEURODIAGNOSTICS MARKET: EDITION DETAILS

TABLE 132. GLOBAL NEURODIAGNOSTICS MARKET: LICENSE DETAILS

TABLE 133. GLOBAL NEURODIAGNOSTICS MARKET: PRICING DETAILS